Intellipharmaceutics International Inc. Annual Operating Income (Loss) in USD from 2017 to 2022

Taxonomy & unit
us-gaap: CAD and USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Intellipharmaceutics International Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2022.
  • Intellipharmaceutics International Inc. Operating Income (Loss) for the quarter ending August 31, 2023 was -$1.79M, a 388% decline year-over-year.
  • Intellipharmaceutics International Inc. Operating Income (Loss) for the twelve months ending August 31, 2023 was -$2.58M, a 31.9% increase year-over-year.
  • Intellipharmaceutics International Inc. annual Operating Income (Loss) for 2022 was -$2.85M, a 31.7% increase from 2021.
  • Intellipharmaceutics International Inc. annual Operating Income (Loss) for 2021 was -$4.17M, a 10.8% increase from 2020.
  • Intellipharmaceutics International Inc. annual Operating Income (Loss) for 2020 was -$4.68M, a 40.3% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$2.85M +$1.32M +31.7% Dec 1, 2021 Nov 30, 2022 20-F/A 2024-02-06
2021 -$4.17M +$505K +10.8% Dec 1, 2020 Nov 30, 2021 20-F/A 2024-02-06
2020 -$4.68M +$3.16M +40.3% Dec 1, 2019 Nov 30, 2020 20-F/A 2024-02-06
2019 -$7.83M +$5.49M +41.2% Dec 1, 2018 Nov 30, 2019 20-F/A 2022-05-09
2018 -$13.3M -$5.06M -61.2% Dec 1, 2017 Nov 30, 2018 20-F 2021-03-31
2017 -$8.27M Dec 1, 2016 Nov 30, 2017 20-F 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.